Antiviral activity of triptolide on herpes simplex virus in vitro

Abstract Background Herpes simplex virus‐type 1 (HSV‐1) can cause diseases, especially amongst neonates and immunocompromised hosts. Hence, developing a novel anti‐HSV‐1 drug with low‐level toxicity is vital. Triptolide (TP), a diterpenoid triepoxide is a natural product with range of bioactivity qu...

Full description

Bibliographic Details
Main Authors: Nasrin Aliabadi, Marzieh Jamalidoust, Gholamreza Pouladfar, Atoosa Ziyaeyan, Mazyar Ziyaeyan
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.667